Loading...
XNAS
SGHT
Market cap465mUSD
Aug 28, Last price  
8.55USD
Name

Sight Sciences Inc

Chart & performance

D1W1MN
XNAS:SGHT chart
P/E
P/S
6.01
EPS
Div yield, %
Shrs. gr., 5y
2.20%
Rev. gr., 5y
22.86%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
IPO date
Jul 15, 2021
Employees
250
Domiciled in
US
Incorporated in
US

Valuation

No data to show